BeiGene Ltd ADR (BGNE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

C/O MOURANT GOVERNANCE SERVICES (CAYMAN) GRAND CAYMAN, CAYMAN ISLANDS KY1-1108

BeiGene, Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovery and development of immuno-oncology drugs that address severe unmet medical needs in a variety of cancer indications. BeiGene serves patients worldwide.

Data based on most recent fiscal year report
Market Cap7.514 Billion Shares Outstanding45.54 Million Avg Volume390.857 Thousand
1-Yr BETA vs S&P TR Current Ratio6.09 Quick Ratio6.02
View SEC Filings from BGNE instead.
Q1 2019 All Institutions Hedge Funds 1
To trade BGNE now:
Filers who had this stock in their top 10: 9 3 (0.31%)
13F Filers holding this stock: 193 21 (2.14%)
Aggregate 13F shares on 03/31/2019: 48.545 Million 14.775 Million
Aggregate 13F shares on 12/31/2018: 47.673 Million 14.86 Million
Percent change: 1.83% -0.57%
Funds creating new positions: 32 4
Funds Adding to an existing position: 69 4
Funds closing out their position: 25 4
Funds reducing their position: 54 5
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BGNE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

14.3 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OYLER JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
64,505,685 2019-07-08 6

WANG XIAODONG

  • Director
  • CHAIR, SCIENTIFIC ADVISORY BRD
12,784,000 2019-07-01 8

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
32,711,292 2019-06-28 1

LIANG HOWARD CFO & CHIEF STRATEGY OFFICER

  • Officer
122,317 2019-06-27 4

HUANG JANE CMO, HEMATOLOGY

  • Officer
328,873 2019-06-27 7

MALLEY THOMAS

  • Director
0 2019-06-25 1

YI QINGQING

  • Director
0 2019-06-17 2

BAKER BROS. ADVISORS LP

14159, L.P.

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
32,431,899 2019-06-06 1

GLAZER DONALD W.

  • Director
0 2019-06-05 5

CHEN TIMOTHY YUNG-CHENG

  • Director
0 2019-06-05 1

SU JINGSHYH S

  • Director
0 2019-06-05 1

WU XIAOBIN PRESIDENT & GM CHINA

  • Officer
1,509,956 2019-06-05 2

PETERSON AMY C. CMO, IMMUNO-ONCOLOGY

  • Officer
194,569 2018-12-17 3

LI JI EVP AND GL. HEAD OF BUS. DEV.

  • Officer
475,000 2018-02-28 0

HILLHOUSE CAPITAL MANAGEMENT, LTD.

  • 10% Owner
71,139,367 2018-01-22 0

TANG KE

  • Director
0 2017-04-19 0

YANG JIANXIN SR. VP, HEAD OF CLINICAL DEV.

  • Officer
0 2016-07-13 0

YAN WENDY XIAOJUN SR. VP, HEAD OF REG. AFFAIRS

  • Officer
0 2016-07-13 0

MERCK & CO., INC.

MERCK SHARP & DOHME CORP.

MERCK SHARP & DOHME RESEARCH GMBH

  • 10% Owner
31,589,038 2016-02-08 0

CB BIOTECH INVESTMENT LTD

CPECHINA FUND, L.P.

CITIC PE ASSOCIATES, L.P.

CITIC PE FUNDS LTD

  • 10% Owner
No longer subject to file 2016-02-08 0

YUAN RUIRONG CHIEF MEDICAL OFFICER

  • Officer
130,000 2016-02-08 0

KRISHANA RANJEEV

  • Director
0 2016-02-02 0

GOLLER MICHAEL

  • Director
0 2016-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2019-07-08 S 100 $128.80 d 0 64,505,685.00 direct yes

OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2019-07-08 S 1,200 $125.59 d 1,906 64,505,685.00 direct yes

OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2019-07-08 S 1,087 $127.89 d 100 64,505,685.00 direct yes

OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2019-07-08 S 719 $127.19 d 1,187 64,505,685.00 direct yes

WANG XIAODONG - Director CHAIR, SCIENTIFIC ADVISORY BRD

2019-07-01 S 2,647 $126.73 d 0 12,784,000.00 direct yes

WANG XIAODONG - Director CHAIR, SCIENTIFIC ADVISORY BRD

2019-07-01 S 2,200 $126.14 d 2,647 12,784,000.00 direct yes

LIANG HOWARD - Officer CFO & CHIEF STRATEGY OFFICER

2019-06-27 S 5,876 $9.47 d 122,317 122,317.00 direct

HUANG JANE - Officer CMO, HEMATOLOGY

2019-06-27 S 3 $126.33 d 0 328,873.00 direct yes

HUANG JANE - Officer CMO, HEMATOLOGY

2019-06-27 S 427 $124.50 d 3 328,873.00 direct yes

YI QINGQING - Director

2019-06-17 J 9,282 d 0 0.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner

667, L.P. - Director - > 10% Owner

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner

BAKER FELIX - Director - > 10% Owner

BAKER JULIAN - Director - > 10% Owner

2019-06-06 J 43,109 a 43,109 17,089,476.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner

667, L.P. - Director - > 10% Owner

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner

BAKER FELIX - Director - > 10% Owner

BAKER JULIAN - Director - > 10% Owner

2019-06-06 J 13,516 a 20,618 17,089,476.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2019-06-06 J 582,200 d 18,591 17,089,476.00 indirect

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2019-06-06 J 182,539 d 1,028,034 17,089,476.00 indirect

BAKER BROS. ADVISORS LP - Director - > 10% Owner

667, L.P. - Director - > 10% Owner

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner

BAKER FELIX - Director - > 10% Owner

BAKER JULIAN - Director - > 10% Owner

2019-06-06 J 43,109 a 43,109 17,089,476.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner

667, L.P. - Director - > 10% Owner

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner

BAKER FELIX - Director - > 10% Owner

BAKER JULIAN - Director - > 10% Owner

2019-06-06 J 13,516 a 20,618 17,089,476.00 direct

OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2019-06-05 A 2,193,282 a 2,193,282 0.00 direct

HUANG JANE - Officer CMO, HEMATOLOGY

2019-06-05 A 62,842 a 334,463 334,463.00 direct

SU JINGSHYH S - Director

2019-06-05 A 64,610 a 64,610 0.00 direct

CHEN TIMOTHY YUNG-CHENG - Director

2019-06-05 A 64,610 a 64,610 0.00 direct

GLAZER DONALD W. - Director

2019-06-05 A 64,610 a 64,610 0.00 direct

YI QINGQING - Director

2019-06-05 A 64,610 a 64,610 0.00 direct

LIANG HOWARD - Officer CFO & CHIEF STRATEGY OFFICER

2019-06-05 A 558,285 a 558,285 128,193.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2019-06-05 A 129,220 a 129,220 17,089,476.00 indirect

WU XIAOBIN - Officer PRESIDENT & GM CHINA

2019-06-05 A 797,550 a 797,550 1,509,956.00 direct

MALLEY THOMAS - Director

2019-06-05 A 64,610 a 64,610 0.00 direct

HUANG JANE - Officer CMO, HEMATOLOGY

2019-06-05 A 462,579 a 462,579 334,463.00 direct

LIANG HOWARD - Officer CFO & CHIEF STRATEGY OFFICER

2019-06-05 A 75,855 a 128,193 128,193.00 direct

WANG XIAODONG - Director CHAIR, SCIENTIFIC ADVISORY BRD

2019-06-05 A 747,708 a 747,708 0.00 direct

WU XIAOBIN - Officer PRESIDENT & GM CHINA

2019-06-05 A 433,472 a 1,505,956 1,509,956.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments